ProCE Banner Activity

Slides on Diagnosis, Management, and Monitoring of IBD

Slideset Download

Hear from gastroenterology experts on the latest insights about IBD care, including early diagnosis, recent advances in therapy, treat to target, therapeutic drug monitoring, and more!

Released: November 03, 2022

Share

Faculty

Abigail Meyers

Abigail Meyers, PA-C

Instructor in Surgery
Physician Assistant
Colon and Rectal Surgery
Mayo Clinic
Rochester, Minnesota

Bruce E. Sands

Bruce E. Sands, MD, MS

Dr. Burrill B. Crohn Professor of Medicine
Chief of the Dr. Henry D. Janowitz Division of Gastroenterology

Mount Sinai Hospital
Chief, Division of Gastroenterology
Mount Sinai Health System
Director, Digestive Disease Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by the American Gastroenterology Association.

ProCE Banner
ProCE Banner

Supporters

This educational activity is supported by educational grants from

Amgen, Inc.

Ferring Pharmaceuticals, Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Faculty Disclosure

Primary Author

Abigail Meyers, PA-C

Instructor in Surgery
Physician Assistant
Colon and Rectal Surgery
Mayo Clinic
Rochester, Minnesota

Abigail Meyers, PA-C: consultant/advisor/speaker: Boston University, myCME.

Bruce E. Sands, MD, MS

Dr. Burrill B. Crohn Professor of Medicine
Chief of the Dr. Henry D. Janowitz Division of Gastroenterology

Mount Sinai Hospital
Chief, Division of Gastroenterology
Mount Sinai Health System
Director, Digestive Disease Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Bruce E. Sands, MD, MS has disclosed that he researcher: Janssen, Theravance Biopharma R&D; consultant: Abivax, AbbVie, Alimentiv, Amgen, Arena, Artugen Therapeutics, AstraZeneca, Bacainn Therapeutics, Boehringer Ingelheim, Boston, Bristol-Myers Squibb, Calibr, Celltrion Healthcare, ClostraBio, Enthera, Evommune, Ferring, Galapagos, Gilead Sciences, GlaxoSmithKline, GossamerBio, Immunic, Index, Innovation, Ironwood, Janssen, Kaleido, Kallyope, Lilly, MiroBio, MRM Health, Morphic Therapeutic, Pfizer, Progenity, Prometheus Biosciences, Protagonist Therapeutics, Q32 Bio, Sun Pharma, Surrozen, Takeda, Target RWE, Teva Branded Pharmaceutical Products R&D, Thelium, Theravance Biopharma R&D, TLL Pharma, USWM Enterprises, Ventyx Biosciences, Viela Bio; ownership interest: Ventyx Biosciences.